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a  b  s  t  r  a  c  t
The  introduction  of  novel  proteins  to food  products  carries  with  it the need  to  assess  the
potential allergenicity  of  such  materials.  Resistance  to in  vitro pepsin  digestion  is  one  param-
eter  considered  in  such  a risk assessment  using  a weight  of  evidence  approach;  however,  the
methodology used  to investigate  this  has  not  been  fully  standardised.  In  vitro  pepsin  resis-
tance assays  typically  involve  SDS-PAGE  performed  under  reducing  conditions,  with  limited
published data  available  on the  assay  using  non-reducing  conditions  despite  the  need  to
consider  non-reducing  analysis  techniques  having  been  highlighted  by  regulatory  bodies
such  as  the European  Food  Safety  Authority  (EFSA).  The  purpose  of  the  work  reported  here
was to investigate  the  applicability  of  (and  additional  insight  provided  by)  non-reducing
analyses,  by  digesting  a set of  proteins  using  a ring-trial  validated  method,  with  analysis  by
SDS-PAGE under  both  reducing  and  non-reducing  conditions.  In silico  prediction  of  digest
fragments  was  also  investigated.  Signiﬁcant  differences  were  observed  between  results
under reduced  and  non-reduced  conditions  for proteins  in  which  disulphide  bonds  have
a major  role  in protein  structure,  such  as  ribulose  1,5-diphosphate  carboxylase  (RUBISCO)
and bovine  serum  albumin.  For  proteins  with  no  or few  disulphide  bonds,  no signiﬁcant  dif-
ferences  were  seen  in  the  results.  Structural  information  such  as disulphide  bond  numbers
and positions  should  be considered  during  experimental  design,  as a non-reduced  approach
may be  appropriate  for some  proteins.  The  in  silico  approach  was  a useful  tool  to suggest
potential  digest  fragments,  however  the  predictions  were  not  always  conﬁrmed  in  vitro  and
should be considered  a guide  only.
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1. Introduction
The introduction of novel proteins to food products car-
ries  with it the need to assess the potential allergenicity
of such materials and this is currently undertaken using
a  weight of evidence approach, consistent with consulta-
tion  reports and guidelines published by expert scientiﬁc
bodies including the Food and Agriculture Organisation of
the  United Nations/World Health Organisation (FAO/WHO
[1]),  Codex Alimentarius Commission (Codex [2]) and the
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European Food Safety Authority (EFSA [3]). In vitro resis-
tance  to pepsin digestion is one of the pieces of evidence
for such an assessment with consideration given to both
the  speed of digestion and the size of fragments formed.
Currently little is known about the relationship between
pepsin resistance and ability to sensitise, but there is a
clear  rationale for a correlation with the potential to elicit
allergic  reactions via ingestion, including in vivo evidence
(animal and human) that there is a minimum peptide size
able  to elicit a Type 1 allergic response in the order of
2–3  kDa (Poulsen and Hau [4], Van Hoeyveld et al. [5], and
Terheggen-Lagro et al. [6]).
It is generally recognised that variations in assay condi-
tions  employed can have a large impact on the digestibility
 access article under the CC BY-NC-ND license
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Table 1
Protein information.
Protein UnitProtKB accession number Approximate protein mass (kDa) Disulphide bonds
-Lactoglobulin P02754 19.9 2
Bovine serum albumin P02769 69.3 17
Concanavalin A P02866 31.5 None
RUBISCO
P00875  (large chain) 52.7 (Large) 4
20.3 (Small)
Q43832 (small chain) 584 (Whole protein) Large subunits present in
dimers formed by S S bonds8 Large and 8 small subunits present in
whole protein.
–44 (Gl
 
 
o
p
f
a
i
c
a
e
t
p
n
t
f
u
r
g
p
d
t
u
c
i
r
b
n
r
m
i
c
f
r
a
a
p
a
n
E
t
f
f
n
o
PHorseradish peroxidase P00433 38.8
Ovalbumin P01012 42.9
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f proteins in vitro and a ring-trial validated protocol for
epsin  resistance assays has subsequently become a de
acto  standard method [7].
In recent years, attempts have been made to develop
pproaches and models that aim to closely replicate human
n  vivo digestion, however these have not been systemati-
ally assessed to determine if they are more predictive of
llergenic  potential. Thus the method proposed by Thomas
t  al. is used in-house by this group to provide informa-
ion on the pepsin resistance of proteins for risk assessment
urposes. The method proposed by Thomas et al. [7] does
ot  (nor does it seek to) replicate human in vivo diges-
ion but serves as a standardised (at least partially) method
or  comparing the pepsin resistance of proteins in a well
nderstood context.
Analysis  for samples from this assay is generally car-
ied  out using sodium dodecyl sulphate-polyacrylamide
el electrophoresis (SDS-PAGE). However the standard
rotocol for SDS-PAGE is performed under reducing con-
itions  in which all disulphide bonds are reduced prior
o  analysis. This may  lead to the observed digestion prod-
cts  appearing smaller than they are under non-reducing
onditions due to the breaking of disulphide bonds hold-
ng  multiple fragments together. This may  not accurately
eﬂect the situation in vivo, as disulphide bonds may  not be
roken  in the stomach. In addition, larger fragments origi-
ally  held together by disulphide bonds may  be too small to
esolve  under SDS-PAGE analysis following reduction and
ay  not be observed at all.
Disulphide bonds are an important structural feature
n  several well known plant allergen families, as dis-
ussed by Hauser et al. [8], and allergens from several
amilies (2S albumins, chitinases) have been shown to
etain  allergenicity following pepsin digestion, even when
ppearing extensively digested under reducing SDS-PAGE
nalysis.
This  suggests that for proteins with numerous disul-
hide bonds, the accepted analysis method may  not be
ppropriate, as large disulphide-linked fragments would
ot  be detected. Indeed this was recognised in a recent
FSA Opinion [3] that recommended ‘If the test protein con-
ains  disulphide bridges, the presence of potential larger
ragments containing re-associated disulphide-bonded
ragments should be veriﬁed by isolation and determi-
ation under non-reducing conditions.’ The potential use
f  both reducing and non-reducing conditions for SDS-
AGE  for in vitro pepsin resistance assays, and need forycosylated) 4
1
None
careful  consideration of method details and data interpre-
tation when using SDS-PAGE was  also discussed by Mills
et  al. [9]. Despite this there are few examples in the pub-
lished literature of non-reduced SDS-PAGE analysis being
performed when studies of resistance to pepsin digestion
are  carried out. Moreno et al. [10] studied the stability
of Brazil nut 2S albumin (Ber e 1) under both reducing
and non-reducing conditions, and concluded that the con-
served  skeleton of cysteine residues played a critical role in
maintaining  the protein’s core structure during proteolysis.
Koppelman et al. [11] also studied Ber e 1 and demon-
strated that reduction and alkylation of cysteine residues
prior to treatment with pepsin rendered the protein highly
susceptible to hydrolysis, highlighting the key role of the
disulphide bridge in protein stability. Koppelman et al. [12]
also  studied a range of peanut allergens and demonstrated
that proteolysis for key allergens Ara h 2 and Ara h 6 could
only  be demonstrated under reducing conditions.
Taking all of this into account, the aim of this study
was to highlight some methodological considerations
around the pepsin resistance assay and its interpretation
in the light of allergenicity prediction, and suggest some
reﬁnements to improve the value of the information it
generates. More speciﬁcally the study aimed to investi-
gate the applicability of (and additional insight provided
by)  non-reducing analyses, by digesting a selection of
proteins using a ring-trial validated method, with analy-
sis  by SDS-PAGE under both reducing and non-reducing
conditions.
2. Materials & methods
2.1.  Pepsin activity
A  ratio of 10 U of pepsin activity/g test protein was
used throughout the study, as described by Thomas et al.
[7].  Pepsin from porcine gastric mucosa (product num-
ber  P7012) was  purchased from Sigma-Aldrich Company
Ltd  (Dorset, UK) for use in the study, with activity of
2913 U/mg protein as analysed by the supplier. The ratio
of  pepsin/protein in the digestion incubate was approxi-
mately 3:1 (w:w).2.2.  Test proteins
The  majority of test proteins chosen for this study were
from  the list of proteins studied by Thomas et al. [7],
ogy Rep
tial  fragments of pepsin digestion were examined in the
context  of the sequence to determine whether the result-860 J. Pickles et al. / Toxicol
and all were sourced from Sigma-Aldrich. The proteins
studied were bovine -lactoglobulin (BLG, product num-
ber  L0130), bovine serum albumin (BSA, product number
A0281), concanavalin A from Jack beans (ConA, prod-
uct  number C2010), ribulose 1,5-diphosphate carboxylase
from spinach leaves (RUBISCO, product number R8000),
horseradish peroxidase (HRP, product number P6782) and
chicken  ovalbumin (Ova, product number A5503)
An additional protein, the common milk allergen -
casein (BCas, product number C6905), not used in the
Thomas study was included to widen the set of proteins
studied.
A  summary of information regarding the test pro-
teins, including protein mass and disulphide bond numbers
(sourced from UniProt Knowledge Base, www.uniprot.org)
and allergen status according to Thomas et al. [7] is given
in  Table 1.
2.3.  Pepsin resistance assay conditions
A single pH (pH2) was used for the digestion of all the
proteins in this study, to maximise the formation of frag-
ments.
For  each test protein, vials were prepared for each time-
point  containing pepsin solution (∼5.5 mg/ml  in 0.06 M
sodium  chloride, pH2) and incubated at 37 ◦C. Test protein
solution (∼8 mg/ml  in ultrapure water (MilliQ system, Mil-
lipore,  Watford, UK), except RUBISCO which was  prepared
in  50 mM Tris–HCl pH9.5 due to solubility constraints) was
added,  such that the ﬁnal concentrations in the incubates
were approximately 4 mg/ml  pepsin and 1.3 mg/ml  test
protein  (3:1 (w:w)). At each timepoint (30 s, 2 min, 5 min,
10  min, 20 min, 30 min  and 60 min) samples (n = 2) were
stopped with sodium carbonate (0.8 M,  0.57 ml/ml  incu-
bate)  and neutralised with concentrated hydrochloric acid
(50%  solution, 0.075 ml/ml  incubate), to give a ﬁnal concen-
tration  of approximately 0.8 mg/ml  test protein. T0 samples
were  prepared by the addition of sodium carbonate to
pepsin  solution prior to the addition of the test protein
solution. A reagent blank was also prepared, using ultra-
pure  water in place of the test protein solution. A test
protein standard was prepared for analysis alongside the
samples,  by diluting the test protein solution to approxi-
mately 0.8 mg/ml.
2.4. SDS-PAGE electrophoresis
Digest  samples and the reagent blank and standard sam-
ples  were further diluted 1 in 4 in reducing or non-reducing
sample buffer (XT sample buffer (Bio-Rad Laboratories
Ltd., Hemel Hempstead, UK) ±100 mM dithiothreitol) prior
to  SDS-PAGE electrophoresis according to the method of
Schägger  and von Jagow [13]. Reduced and non-reduced
samples were run on separate gels, however for each gel a
standard  of the opposite reduction status was run along-
side  the samples, to allow an on-gel comparison of the
migration of the reduced/non-reduced parent protein.Prior  to application to the gel, all samples were
heated in a boiling water-bath for 5 min. Then 10 l
of  prepared solutions were applied to the appropriate
lanes of a Criterion Peptide 12 + 2 well 10–20% linearorts 1 (2014) 858–870
gradient gel (Bio-Rad) and electrophoresis performed using
Tris–Tricine–SDS running buffer. Molecular weight mark-
ers  (Invitrogen Novex sharp markers (3.5–260 kDa, (Life
Technologies Ltd., Paisley, UK)) & Bio-Rad polypeptide
SDS-PAGE standard (1.4–26.6 kDa, Bio-Rad)) were run
concurrently on all gels to enable molecular weight deter-
mination. The Bio-Rad polypeptide standard was  diluted in
reducing  sample buffer prior to application to gels for both
analysis  conditions. Novex sharp markers were applied
to  the gel undiluted. Molecular weights for non-reduced
samples calculated against reduced standards should be
considered estimations only, as intact disulphide bonds can
alter  the shape of the molecule and therefore the apparent
molecular weight under SDS-PAGE conditions.
2.5. Gel staining
2.5.1.  1X Krypton total protein staining
For all samples the gels were ﬁxed in aqueous 40%
(v:v) ethanol/10% (v:v) acetic acid for two  30 min  periods,
before washing in ultrapure water for 5 min. The gels
were stained overnight in aqueous 1X Krypton (Thermo
Scientiﬁc (Pierce), Hemel Hempstead, UK) stain before
destaining with aqueous 5% (v:v) acetic acid for a minimum
of  5 min. Finally the gels were washed in ultrapure water
for  two 15 min  periods. All staining steps were performed
under gentle agitation using an orbital mixer.
2.5.2. Coomassie Blue R-250 gel staining
For BSA a repeat analysis was performed using
Coomassie Blue staining. The gels were ﬁxed in aqueous
40% (v:v) methanol/10% (v:v) acetic acid for 1 h before
staining overnight in neat Coomassie Brilliant Blue R-250
stain  (Bio-Rad). The stained gels were then destained in
two  changes of aqueous 40% (v:v) methanol/10% (v:v)
acetic acid, for 15 min, until a satisfactory background was
achieved,  before washing in ultrapure water for 1 h. All
staining steps were performed under gentle agitation using
an  orbital mixer.
2.5.3.  Gel imaging and analysis
Fluorescently stained (Krypton) gel images were cap-
tured  using the Typhoon Trio+ variable mode imager and
Scanner  control software. Coomassie Blue stained gels were
captured  using the Imagescanner II with Labscan software
(version 5). The gel images were analysed using TotalLab
TL120 software.
2.6.  In silico pepsin proteolysis
In silico analysis of the potential digestion fragments
for RUBISCO, HRP and BSA was  performed using Peptide
Cutter (http://web.expasy.org/peptide cutter/). The poten-ing  peptides could be linked by disulphide bonds to form
larger  fragments, using disulphide bond position informa-
tion  taken from the UniProt Knowledge Base entry for each
protein.
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igest  samples) (Lane 5), digest samples (Timepoints: T0, 0.5, 2, 5, 10, 20,
. Results and discussion
The  images obtained for each test protein under reduced
nd  non-reduced analysis conditions were compared, and
ifferences  in the distribution and lifespan of any frag-
ents formed was noted and interpreted with reference
o  information available about protein structure, and disul-
hide  bond arrangements (Table 1). The selected proteins each gel the lanes contain: Novex sharp markers (Lane 1), test protein
e 3), pepsin blank (Lane 4), test protein blank (same reduction status as
in) (Lanes 6–13) and polypeptide SDS-PAGE standards (Lane 14).
had  a variety of disulphide bond arrangements; none
(ConA, BCas), few (1 or 2, Ova, BLG) and many (4+, BSA,
RUBISCO, HRP). The following proteins originally used by
Thomas  et al. [7] were not included in this work: Ara
h  2 could not be commercially sourced, and was  omit-
ted  as the non-reduced analysis of its digestion fragments
had already been published by Koppelman et al. [12].
Phosphinothricin acetyltransferase (PAT) could also not be
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Fig. 2. Reduced (A) and non-reduced (B) analyses of BCas. From left to right for each gel the lanes contain: Novex sharp markers (Lane 1), test protein blank
ne 3), p
 min) (L
(opposite  reduction status to digest samples) (Lane 2), sample buffer (La
samples)  (Lane 5), digest samples (Timepoints: T0, 0.5, 2, 5, 10, 20, 30, 60
commercially sourced. Kunitz soybean trypsin inhibitor
(STI) was not studied as it was extremely resistant to
digestion, with limited fragment formation observed in
the  Thomas study. In addition, ovomucoid was also omit-
ted,  due to analysis problems reported in the Thomas
study.epsin blank (Lane 4), test protein blank (same reduction status as digest
anes 6–13) and polypeptide SDS-PAGE standards (Lane 14).
3.1. Comparison of reduced and non-reduced analyses
for test proteins3.1.1.  No or few disulphide bonds
BCas and ConA have no disulphide bonds, therefore no
differences were expected between the analyses. These
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Fig. 3. Reduced (A) and non-reduced (B) analyses of Ova. From left to right for each gel the lanes contain: Novex sharp markers (Lane 1), test protein blank
( ne 3), p
s min) (La
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aopposite  reduction status to digest samples) (Lane 2), sample buffer (La
amples)  (Lane 5), digest samples (Timepoints: T0, 0.5, 2, 5, 10, 20, 30, 60 
A)  in which the pepsin blank and reduced Ova standard were reversed.
roteins were used as negative controls to verify whether
he  use of a non-reducing sample buffer would affect the
el  images obtained. Ova and BLG have 1 and 2 disul-
hide bonds respectively, and only limited differences
ere expected. For all four proteins no signiﬁcant differ-
nces  were observed between the gel images for reduced
nd  non-reduced analyses (Figs. 1–4). Where digestionepsin blank (Lane 4), test protein blank (same reduction status as digest
nes 6–13) and polypeptide SDS-PAGE standards (Lane 14), except for gel
fragments were observed (ConA, Ova, BCas) no signiﬁcant
differences in the appearance and lifespan of the fragments
were noted. Despite being a known allergen, BCas was
rapidly digested with no signiﬁcant fragments remaining
at  the end of the digestion time course suggesting that
its  immunological activity may  be based on aggregates
of smaller fragments, as discussed by Benedé et al. [14].
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Fig. 4. Reduced (A) and non-reduced (B) analyses of BLG. From left to right for each gel the lanes contain: Novex sharp markers (Lane 1), test protein blank
e 3), pe
0 min) ((opposite  reduction status to digest samples) (Lane 2), sample buffer (Lan
samples)  (Lane 5), digest samples (Timepoints: T0, 0.5, 2, 5, 10, 20, 30, 6
added  to the pepsin blank samples in error.
It was noted that Ova was digested more rapidly than
had  been reported by Thomas et al. [7], and there was
no  evidence of the fragment formation observed in that
earlier  work. This could be due to the use of a different
staining method in the current study, however a similar
digestion proﬁle for Ova was reported by Dearman et al.
[15].psin blank * (Lane 4), test protein blank (same reduction status as digest
Lanes 6–13) and polypeptide SDS-PAGE standards (Lane 14). * BLG was
3.1.2.  Many disulphide bonds
No  major differences were observed between reduced
and non-reduced analysis of HRP (Fig. 5), despite the
parent protein containing four disulphide bridges. No sig-
niﬁcant  digestion fragments were observed. It appears that
the  protein is primarily cleaved by pepsin in positions
such that the fragments formed are not held together
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eig. 5. Reduced (A) and non-reduced (B) analyses of HRP. From left to righ
opposite  reduction status to digest samples) (Lane 2), sample buffer (La
amples)  (Lane 5), digest samples (Timepoints: T0, 0.5, 2, 5, 10, 20, 30, 60
y S S bonds and give rise to only a very minor dif-
erence between the reduced and non-reduced analyses.
nalysis of the predicted digestion from Peptide Cut-
er  suggested that three potential fragments consisting
f smaller peptide sequences held together by disul-
hide bonds could be formed following pepsin hydrolysis,
ith the largest containing 55 amino acids (∼6 kDa). No
vidence of these potential fragments was seen in the
xperimental data. It was  noted that the parent proteinh gel the lanes contain: Novex sharp markers (Lane 1), test protein blank
epsin blank (Lane 4), test protein blank (same reduction status as digest
anes 6–13) and polypeptide SDS-PAGE standards (Lane 14).
appeared more persistent than in the digestion assay
performed by Thomas et al. [7], with a faint band still vis-
ible  following 60 min  of digestion, under both reducing
and non-reducing conditions. No other evidence regarding
in  vitro HRP pepsin resistance could be located in the
literature.
In  contrast, RUBISCO and BSA both demonstrated sig-
niﬁcant differences between reduced and non-reduced
analyses (Figs. 6–8).
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Fig. 6. Reduced (A) and non-reduced (B) analyses of RUBISCO. From left to right for each gel the lanes contain: Novex sharp markers (Lane 1), test protein
fer (Lan
, 30, 60 mblank  (opposite reduction status to digest samples) (Lane 2), sample buf
digest  samples) (Lane 5), digest samples (Timepoints: T0, 0.5, 2, 5, 10, 20
parent  band highlighted in non-reduced image.For RUBISCO bands were seen for both the large and
small subunits (∼53 and 20 kDa) in the standard and T0
samples under reducing conditions. Although the protein
itself  was rapidly digested, with the large and small subunite 3), pepsin blank (Lane 4), test protein blank (same reduction status as
in) (Lanes 6–13) and polypeptide SDS-PAGE standards (Lane 14). Intactbands  no longer visible by 30 s, a number of digestion frag-
ments  were observed in the 10–13 kDa region, persisting
until 30 min. Under non-reduced conditions no signiﬁcant
bands were observed for the standard sample, however a
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tig. 7. Reduced (A) and non-reduced (B) analyses of BSA under Krypton s
arkers  (Lane 1), test protein blank (opposite reduction status to digest sa
same  reduction status as digest samples) (Lane 5), digest samples (Time
tandards  (Lane 14).
tained region at the top of the lane was observed. Bands
or  a dimer of the large subunit at ∼110 kDa (held by
n  intact disulphide bond under non-reducing conditions)
nd  the small subunit were expected but not observed; it
ppears  that when the disulphide bonds are not reduced
he  quaternary structure of the parent protein complexconditions. From left to right for each gel the lanes contain: Novex sharp
 (Lane 2), sample buffer (Lane 3), pepsin blank (Lane 4), test protein blank
T0, 0.5, 2, 5, 10, 20, 30, 60 min) (Lanes 6–13) and polypeptide SDS-PAGE
remains stable under the analysis conditions. The intact
parent complex is so large (∼584 kDa) it cannot migrate
under electrophoresis and so remains at the top of the
lane.  Analysis of the predicted digestion from Peptide Cut-
ter  suggested that a fragment consisting of two identical
16-mer peptides linked by a disulphide bond could be
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ssie Blu
us to dig
mples (Fig. 8. Reduced (A) and non-reduced (B) analyses of BSA under Cooma
Novex  sharp markers (Lane 1), test protein blank (opposite reduction stat
protein  blank (same reduction status as digest samples) (Lane 5), digest sa
SDS-PAGE  standards (Lane 14).
formed from the large subunit dimers, with a MW of
∼3.5  kDa, however this fragment was not observed under
the  conditions used. Fragments in the 8–10 kDa range were
observed, and persisted until 30 min  in a similar pattern
to  the reduced analysis. No signiﬁcant bands remained by
60  min  for either analysis condition; the apparent molec-
ular  weight of fragments observed under non-reducede staining conditions. From left to right for each gel the lanes contain:
est samples) (Lane 2), sample buffer (Lane 3), pepsin blank (Lane 4), test
Timepoints: T0, 0.5, 2, 5, 10, 20, 30, 60 min) (Lanes 6–13) and polypeptide
conditions differed slightly from that seen for the reduced
analysis.
For  BSA low molecular weight (<7 kDa, LMW) frag-
ments were observed under non-reduced conditions. As
this  protein has seventeen disulphide bonds, it is sug-
gested these LMW  fragments may  have been composed
of many very small fragments held together by the
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isulphide bonds. The analysis of BSA digests was  repeated
sing  Coomassie Blue staining (Fig. 8), which gave better
esults on staining than the initial analysis using Krypton
X  staining. Detection of the LMW  fragments in particular
as enhanced using Coomassie Blue, with some fragments
aintly visible under reducing conditions, and seen more
learly  under non-reducing conditions. The fragments vis-
ble  under reducing conditions were not as strongly stained
s  those reported by Thomas et al. [7]. As discussed in
hat  paper, ﬁxing and staining conditions can have a large
mpact  on the detection of fragments in the lower MW
anges. The UniProt KnowledgeBase entry for BSA notes
hat  the protein may  be phosphorylated which may  have
ontributed to the poor staining of the fragments in ini-
ial  analysis with Krypton staining [16]. Analysis of the
equence using Peptide Cutter suggested that there are
even  potential fragments composed of multiple shorter
eptide sequences held by disulphide bonds, ranging from
5  to 43 amino acids (∼1.6–4.7 kDa), which correspond to
he  observed fragments.
.  Conclusions
Proteins with a range of disulphide bond structures
ere studied under reduced and non-reduced analysis in
his  study, and some notable differences in analysis results
ere  observed. Furthermore, in silico prediction of diges-
ion  fragments is a useful complementary tool which may
e  used alongside disulphide bond information to design an
ppropriate  approach to the in vitro assay, however the in
ilico  results do not always reﬂect what is observed exper-
mentally and should be considered a guide only. This is
ikely  due to the accessibility of potential pepsin cleavage
ites within the folded protein structure, as the Peptide Cut-
er  tool only considers the linear sequence. In this paper,
wo  proteins from the set of nine used by Thomas et al.
7]  were shown to have signiﬁcant differences between
educed and non-reduced analyses. In addition another
rotein from the set, the peanut allergen Ara h 2, has previ-
usly  been shown to have signiﬁcantly more resistance to
epsin  digestion when analysed under non-reducing con-
itions  [12]. The proteins were not selected for the original
nalysis based on disulphide bond arrangements, but as a
epresentative set of allergens and non-allergens, and may
ot  be considered an ideal set to study the effect of reduc-
ion  on analysis. Despite this, signiﬁcant differences have
ow  been demonstrated for a third of the original set of
roteins.
Careful  consideration of protein structure is required
hen selecting SDS-PAGE sample conditions to assess the
ragments  resulting from in vitro pepsin digestion. Should
he  protein in question be known to have disulphide
onds present, it would be appropriate for researchers
o consider whether a non-reduced element of analy-
is  should be included in a modiﬁcation of the widely
ccepted, and utilised, Thomas et al. [7] protocol. For pro-
eins  with disulphide bonds studied only under reducing
onditions, signiﬁcant fragments of digestion may  be com-
letely  absent, and a full picture of the pepsin resistance
ould not be achieved. This could have a serious impact
n  the risk assessment of potential allergenicity.rts 1 (2014) 858–870 869
Additionally, comparison of the results obtained with
previously published studies showed some variability in
the  detection of fragments and persistence of parent
proteins during the digestion time course. This may be
attributable to experimental variation and the impact of
different  staining conditions, as the earlier reported work
used  solely Coomassie Blue staining, while the results pre-
sented  herein were obtained with a ﬂuorescent Krypton
stain. Since the Thomas et al. [7] paper was published a
plethora of new ﬂuorescent stains have become available
and  the impact of the use of these in this assay is currently
unclear and worthy of further exploration, such that rec-
ommendations can be standardised with regards to this
aspect  of the assay too. Where a difference in apparent
MW  is observed between reduced and non-reduced anal-
yses,  the use of a complementary technique to determine
accurate MW for digestion fragments may  be necessary, for
example  SEC-MALLS or LC–MS techniques.
In summary, the results reported here highlight that
whilst providing a relatively simple, fast and cost-effective
way of comparing a new protein of interest with known
allergens and non-allergens, it should be recognised that
one  of the most widely accepted and used methods for
assessing pepsin resistance [7] should not be considered
fully standardised. Taking into consideration the protein(s)
under assessment, there may  be value in using different
staining techniques and/or modiﬁcations such as use of
non-reducing SDS-PAGE analysis.
As mentioned brieﬂy in the introduction to this paper,
there has been much interest and effort in recent years in
developing approaches and models to more closely repli-
cate  human in vivo digestion, however the additional value
these  provide with regards to allergenicity risk assess-
ment has not been systematically assessed. Indeed, as has
been  recently concluded as the result of a comprehensive
literature review of this area [9], before a clear consen-
sus can be reached as to what is meant by ‘resistance’
to digestion and the risk implications of such data, there
is  a pre-requisite need for standardised, harmonised test
conditions, and fragment proﬁling, to enable comparison
of test results for a range of reference proteins includ-
ing allergens and non-allergenic controls. To add to the
understanding of the impact of reducing or non-reducing
conditions for such assays, and behaviour of proteins with
multiple  disulphide bonds, a further study is planned. An
expanded set of proteins will be selected with a range of
disulphide bond arrangements, in order to further demon-
strate  the importance of considering non-reduced analyses
in  experimental design.
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